We are a team of passionate scientists, doctors and clinicians, driven to fight late stage cancers.

ABOUT ANVIRON

About our company, our mission and our team.

OUR PIPELINE

Overview of our pipeline and our science

LATEST NEWS

Latest news releases and investor packages 

shutterstock_1647340636_edited.jpg

COMMUNICATIONS

Get regular updates on our company and pipeline

Thanks for submitting!

Our pipeline consists of a promising family of small molecules inhibitors of proteins responsible for unconstrained proliferation signaling and metastasis. 

ANV221 for Pancreatic Cancer

A low toxicity, novel product candidate shown to reduce pancreatic cancer tumor size and suppress metastases superior to approved standard of care drugs in vivo models.